Trials / Conditions / Cerebral Vasospasm

Cerebral Vasospasm

38 registered clinical trials studyying Cerebral Vasospasm — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts NCT06893588	Vesalio	—
Recruiting	Incidence, Characteristics and Evolution of Cerebral Vasospasm With Clinical Impact in Moderate to Severe Trau NCT06560372	University Hospital Center of Martinique	N/A
Completed	Predictive Model for the Occurrence of Cerebral Vasospasm Complicating Subarachnoid Haemorrhage by Combined An NCT06303349	University Hospital, Bordeaux	N/A
Enrolling By Invitation	Cervical Sympathetic Block in Patients With Cerebral Vasospasm NCT05230134	Stanford University	N/A
Terminated	Cervical Spinal Cord Stimulation in Patients With Cerebral Vasospasm After Subarachnoid Haemorrhage: VasoStim NCT05150002	Insel Gruppe AG, University Hospital Bern	N/A
Unknown	Magnesium Treating Subarachnoid Hemorrhage Vasospasm NCT04613960	General Committee of Teaching Hospitals and Institutes, Egypt	Phase 2 / Phase 3
Completed	"The Effect of Stellate Ganglion Block in Severe Brain Injury" NCT04208477	University Medical Centre Ljubljana	N/A
Unknown	Stellate Ganglion Block and Cerebral Vasospasm NCT04691271	Beijing Tiantan Hospital	N/A
Unknown	Stellate Ganglion Block in Preventing Cerebral Vasospasm Secondary to Subarachnoid Hemorrhage NCT04512859	Beijing Tiantan Hospital	N/A
Completed	Safety of Intravenous Milrinone for the Treatment of Subarachnoid Hemorrhage-induced Vasospasm NCT03517670	Nantes University Hospital	—
Completed	Vesalio NeVa VS for Symptomatic Cerebral Vasospasm Following aSAH (The VITAL Study) NCT03611790	Vesalio	N/A
Unknown	Sildenafil for DCI NCT03028298	University of Mississippi Medical Center	Phase 1
Terminated	The Intra-arterial Vasospasm Trial NCT01996436	Peng Roc Chen, MD	Phase 4
Withdrawn	Cervical Spinal Cord Stimulation in Cerebral Vasospasm NCT02426827	Mayo Clinic	N/A
Terminated	Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid NCT02712788	Indiana University	Phase 2
Completed	Role of CT Perfusion in Predicting Poor Outcome After Subarachnoid Hemorrhage NCT03214705	Assiut University	—
Withdrawn	Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage NCT01878136	Rush University Medical Center	Phase 1 / Phase 2
Unknown	Safety and Feasibility of Hypertonic Saline Solution After Aneurysmal Subarachnoid Hemorrhage: NCT02432157	Thomas Jefferson University	Phase 1 / Phase 2
Completed	Acupuncture for Cerebral Vasospasm After Subarachnoid Hemorrhage NCT02275949	Kyung Hee University Hospital at Gangdong	N/A
Completed	Stellate Ganglion Block Using Ultrasound Guidance For Treatment Of Post Clipping Cerebral Vasospasm NCT02775318	Post Graduate Institute of Medical Education and Research, Chandigarh	Phase 1
Unknown	Safety Study of Carotid Body Neurostimulation to Treat Cerebral Vasospasm NCT02129413	Samson NeuroSciences	N/A
Active Not Recruiting	CT Perfusion Imaging to Predict Vasospasm in Subarachnoid Hemorrhage NCT02056769	Nova Scotia Health Authority	N/A
Terminated	Safety Study of Nicardipine to Treat Cerebral Vasospasm NCT01810302	University of Florida	Phase 2
Completed	Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM to Transcranial Doppler as an Aid to Diagnosing NCT01595802	Jan Medical, Inc.	—
Completed	Role of Proteomics and Metallomics in Cerebral Vasospasm Following Subarachnoid Hemorrhage NCT01799018	State University of New York - Upstate Medical University	—
Terminated	Continuous Neurophysiological Monitoring Detection of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage NCT01343537	State University of New York - Upstate Medical University	EARLY_Phase 1
Completed	Identification of Novel Molecular Markers for Vasospasm NCT02389634	St. Joseph's Hospital and Medical Center, Phoenix	—
Completed	Remote Ischemic Preconditioning in Subarachnoid Hemorrhage NCT01158508	University of California, Los Angeles	Phase 1
Withdrawn	Sildenafil for Prevention of Cerebral Vasospasm NCT01091870	Hospital de Clinicas de Porto Alegre	Phase 2
Completed	Safety Study of Dantrolene in Subarachnoid Hemorrhage NCT01024972	University of Massachusetts, Worcester	Phase 1 / Phase 2
Completed	Computed Tomographic (CT) Perfusion and CT Angiography as Screening Tools for Vasospasm Following Subarachnoid NCT00962546	Washington University School of Medicine	—
Completed	Bilateral Bispectral Index (BIS) Study NCT01187420	Icahn School of Medicine at Mount Sinai	—
Completed	Quality of Life in Elderly After Aneurysmal Subarachnoid Hemorrhage (SAH) NCT00692744	University Hospital, Rouen	—
Withdrawn	Safety Study of Sildenafil in Treatment of Cerebral Aneurysm Vasospasm NCT00871065	University of Nebraska	Phase 2
Terminated	Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage NCT00487461	University of Illinois at Chicago	N/A
Terminated	Use of Brain Oxygen Tension Level and Cleaved-tau Protein to Detect Vasospasm After SAH NCT00582868	University of Wisconsin, Madison	—
Terminated	Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm NCT00585559	Vanderbilt University Medical Center	Phase 3
Completed	Eicosapentaenoic Acid Cerebral Vasospasm Therapy Study NCT00839449	Yamaguchi University Hospital	Phase 4